Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Depreciation & Amortization (CF) (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Depreciation & Amortization (CF) for 15 consecutive years, with $13.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 18.23% year-over-year to $13.1 million, compared with a TTM value of $77.3 million through Dec 2025, up 28.74%, and an annual FY2025 reading of $77.3 million, up 28.74% over the prior year.
  • Depreciation & Amortization (CF) was $13.1 million for Q4 2025 at Orthofix Medical, up from $12.9 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $34.4 million in Q1 2025 and bottomed at $6.5 million in Q2 2022.
  • Average Depreciation & Amortization (CF) over 5 years is $12.5 million, with a median of $13.0 million recorded in 2025.
  • The sharpest move saw Depreciation & Amortization (CF) decreased 20.81% in 2021, then skyrocketed 131.67% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $7.4 million in 2021, then fell by 0.34% to $7.4 million in 2022, then surged by 88.24% to $14.0 million in 2023, then grew by 14.5% to $16.0 million in 2024, then dropped by 18.23% to $13.1 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for OFIX at $13.1 million in Q4 2025, $12.9 million in Q3 2025, and $16.9 million in Q2 2025.